Prescription drug management program accountability method and system

The embodiments disclose a prescription drug management accountability system, including an opioid drug abuse and risk assessment behavioral mental health test integrated within the prescription drug management accountability system for screening a patient that needs an opioid prescription. The pres...

Full description

Saved in:
Bibliographic Details
Main Authors DeFrank, Antonio, Jones, Allen Mark, DeFrank, Edmond Arthur, DeFrank, Nicolas, Clark, David
Format Patent
LanguageEnglish
Published 21.06.2018
Subjects
DIAGNOSIS
HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATIONTECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING ORPROCESSING OF MEDICAL OR HEALTHCARE DATA
HUMAN NECESSITIES
HYGIENE
IDENTIFICATION
INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS
MEDICAL OR VETERINARY SCIENCE
PHYSICS
SURGERY
Online AccessGet full text

Cover

More Information
Summary:The embodiments disclose a prescription drug management accountability system, including an opioid drug abuse and risk assessment behavioral mental health test integrated within the prescription drug management accountability system for screening a patient that needs an opioid prescription. The prescription drug management accountability system also includes a centralized prescription drug monitoring system that is electronically connected to licensed pharmacies and licensed dispensing entities. The centralized prescription drug monitoring system collects pharmacy prescription information for the patient and produces a report with information on opioid prescriptions of the patient that can be used by a physician with the opioid drug abuse and risk assessment behavioral mental health test before prescribing an opioid.
Bibliography:Application Number: US201715732694